Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

- Check35 days agoChange DetectedThe page updates the revision from v3.0.2 to v3.1.0, indicating a new version is available. If there is no other visible content change, this is a metadata/version update rather than a substantive change to content.SummaryDifference0.1%

- Check50 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as details related to radiation exposure and adenocarcinoma of the esophagus. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%

- Check78 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.